Deep Knowledge Ventures
Co-founder / Managing Partner
Longevity.Capital / Co-founder
Deep Knowledge Analytics / Co-founder
Aging Analytics Agency / Co-founder
BioGerontology Research Foundation
Longevity.International / Co-founder
UK All Party Parliamentary Group for Longevity / Head of International Development of the Secretariat for APPG for Longevity
Dmitry Kaminskiy is an innovative entrepreneur and investor active in the fields of Longevity, Precision Medicine, and Artificial Intelligence. He is co-founder and managing partner at Deep Knowledge Ventures, a leading investment fund focused on DeepTech, renowned for its use of sophisticated analytical systems for investment target identification and due-diligence.
He is a frequent speaker on AI and Longevity, including events organized in London by The Economist “Aging Societies and The Business of Longevity”, Financial Times “Smart Machines vs Smart People”, Financial Times “Global Pharmaceutical and Biotechnology Conference”, the "Precision Medicine World Conference" in Silicon Valley as well as others at Oxford and Cambridge Universities.
He is actively involved in the work of the initiative group and was instrumental at the initial stage of the launch of the All-Party Parliamentary Group for Longevity in the UK Parliament. He now serves as co-director of the secretariat, overseeing the APPG’s international Longevity cooperation development division. He is also supervising all of the APPG’s activities related to the development of Centres of Artificial intelligence for Preventive Medicine in the UK.
Deep Knowledge Ventures Investment Fund and its analytical subsidiary Deep Knowledge Analytics are particularly active in the AI for Drug Discovery sector, starting with its 2014 seed investment in industry leader Insilico Medicine, whereas the Pharma Division of Deep Knowledge Analytics has become the unparalleled leader of deep quantitative analysis of the AI for Drug Discovery sector.
Aging Analytics Agency is the Longevity-focused analytical subsidiary of Deep Knowledge Ventures, and currently serves as the Longevity, Preventive Precision Medicine and Economics of Aging data analytics source for the All-Party Parliamentary Group for Longevity.
In addition to his business activities, Dmitry is involved in several scientific endeavours. He strongly believes that humans should live longer healthier lives. He has a major interest in Healthy Longevity which is reflected in his business, research and public activities.
Dmitry’s $1 million USD prize for the first person to reach their 123th birthday went viral, and was widely covered by the world’s top media. The current lifespan record is 122.5 years, achieved by Jeanne Calment in 1997, which has remained unchanged despite the tremendous advances in biomedicine and in our understanding of the aging process that have occurred since that time. Kaminskiy chose to launchthis prize in order to promote Healthy Longevity, and to motivate people to maximize their own Healthy Longevity. Given the dynamic of progress in the field of Longevity, it is only a matter of time before this record is surpassed through the proactive efforts of someone using all available resources, both scientific, technological and lifestyle-related, to maximize their Healthy Longevity and celebrate his or her 123rd birthday.
Dmitry adheres to the principal of “Impact Investing” in all his business activities, believing that business should intentionally make a significant impact for social good. He operates according to the maxim that business should be aligned with societal good and humanitarianism, and his activities in both business and the non-profit sector are aimed at the shared goal of advancing exponential and disruptive technologies to accelerate positive paradigm shifts in finance, healthcare and AI.
Dmitry’s most prioritized current project is the launch of Longevity.Capital, a specialised investment fund focused on the longevity industry, powered by comprehensive multidimensional analytical system developed by Aging Analytics Agency to structure advanced investment strategy.
Deep Knowledge Ventures www.dkv.global
Data Science driven investment fund focused on strategically-timed investments at the inflection point of technological megatrends, investing in the synergetic convergence of specific DeepTech verticals. The fund is internationally renowned for its use of sophisticated analytical systems for investment target identification and due-diligence.
Longevity.Capital is a specialized Longevity Industry Index Hedge Fund with enhanced liquidity that uses hybrid investment technologies to combine the profitability of venture funds with the liquidity of hedge funds, significantly de-risking the interests of LPs and providing the best and most promising Longevity companies with relevant amounts of investment. The fund is a subsidiary fund of Deep Knowledge Ventures, powered by comprehensive multidimensional analytical systems developed by Aging Analytics Agency to structure advanced investment strategy, sophisticated due diligence operations and pragmatic portfolio companies valuation procedures.
Deep Knowledge Analytics www.dka.global
A leading Deep Tech analytical agency focused on AI, Longevity, Crypto Economy, and Convergence of Technological MegaTrends. The mastermind nexus behind the corporate knowledge and intelligence of the Deep Knowledge Group.
Aging Analytics Agency www.aginganalytics.com
Aging Analytics Agency is the world’s premier provider of industry analytics on the topics of Longevity, Precision Preventive Medicine and Economics of Aging, and the convergence of technologies such as AI, Blockchain, Digital Health and their impact on the healthcare industry. The company provides strategic consulting services in fields relating to Longevity, and currently serves as the primary source of analytics and data for the UK All-Party Parliamentary Group for Longevity.
Biogerontology Research Foundation www.bg-rf.org.uk
Dmitry is well known for his support of life extension think-tanks in Oxford and Cambridge and many other related non-profit activities. He is the Managing Trustee of the Biogerontology Research Foundation, a UK charity expediting the coming paradigm shift from disease treatment to personalized precision prevention.
UK APPG for Longevity www.appg-longevity.org
The All Party Parliamentary Group (APPG) for Longevity was set up in March 2019 to address the scientific, technological and socio-economic issues relating to our ageing demographic and promote living younger, healthier and longer lives.
Longevity International UK www.longevityinternational.org
Longevity International is a social enterprise bringing together start-ups, industry, academic and governmental stakeholders under one umbrella to provide a unified voice and coordinating vehicle for positive discourse and change to ensure the ‘longevity dividend’ is accessible to everyone. Its first geographic focus is the United Kingdom. In order to harness the benefits of longevity, a positive narrative and a bold vision is needed to excite the business community, convince policy makers and convert hearts and minds in the wider public to leverage the opportunities of a longer life and maximise the health and wealth of the nation.
Insilico Medicine www.insilico.com
Deep Knowledge Ventures flagship portfolio company. A leading company applying AI and Deep Learning for drug discovery development of biomarkers of aging.